Legislative & Regulatory Issues
Contact your State Advocacy Coordinator to get involved in advocacy efforts in your state.
- Biosimilar and Interchangeable Drug Products Legislation and Laws
Biosimilar and Interchangeable Drug Products Legislation and Laws as of July, 2018.
- Drug Pricing Summary and Legislation
September 2018: AMCP is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. AMCP supports efforts to reduce drug prices by encouraging both meaningful transparency within health care and robust market competition.
July 2018: One of AMCP’s policy and advocacy focus areas for 2018 is Opioid Management. AMCP has been actively involved on the federal and state levels to increase awareness of the role of managed care pharmacy in support of patient-centered and clinically effective approaches to reduce overuse, diversion, and misuse of prescription opioids.
- Medicare Fraud, Waste & Abuse
The Academy has taken a leading role in the effort to combat fraud, waste and abuse in the Medicare system. The Academy is collaborating with the CMS Outreach and Education MEDIC (Medicare Integrity Contractor) to combat fraud, waste and abuse in Medicare Parts C and D. The collaborative effort stems from AMCP’s work with Congress and the Obama Administration to introduce legislation that would suspend payment of claims to pharmacies where there is a credible allegation of fraud.
- State Exchanges and Essential Health Benefits
Health Insurance Exchanges provide individuals and small businesses with a “one-stop shop” to find and compare affordable, quality health insurance options. With these Exchanges, Americans no longer be on their own in trying to find comprehensive, affordable health coverage. Exchanges bring new transparency to the market so that consumers will be able to compare plans based on price and quality.